This service provides expert guidance for protocol development, set-up and/or the decision to place a study in the UK.
To start a review, we need the following information:
Once you have completed the online submit my study form, the timelines are:
Within the same day:
Within two working days:
Service timelines after three working days:
In order to be eligible for inclusion on the NIHR CRN portfolio, commercial studies i.e. those which are fully commercial, both fully industry supported and partly industry supported must be submitted via this online system by a member of the sponsoring company or Clinical Research Organisation (CRO) for assessment against the following eligibility criteria, as defined by the Department of Health:
The Network will use the information you supplied in the submission to ensure that the above criteria are satisfied, if there are any questions relating to the above, a Network representative will contact the applicant for clarification.
Email our Study Support Help Desk, or call on 0113 34 34 555 to put in place or check for existing agreements.
We treat any information you disclose to us as confidential and do not share it with any unauthorised third party. Our CRN Confidentiality Disclosure Agreement (CDA) puts this in writing.
Information submitted by companies to the CRN in relation to Portfolio eligibility and feasibility assessments can be of a confidential nature therefore arrangements have been put in place, underpinned by a set of generic confidentiality agreements, which facilitate discussions between a company, the Clinical Research Network and researchers while maintaining confidentiality.
These arrangements were developed with the Life-science’s industry through the NIHR Clinical Research Network Industry Roadmap Group and endorsed by the Association of British Pharmaceutical Industry (ABPI). The confidentiality agreements only need to be signed once to cover any future discussions between the Clinical Research Network and companies wishing to submit studies for our feasibility services and inclusion on the Portfolio. Further information regarding the structure of these agreements and what they cover can be found in our guidance document in the list of links below.
These arrangements do not enable the Clinical Research Network to share confidential information with selected study sites in relation to site set-up. The provision of any confidential information to a site research team should be provided by the Sponsor or relevant CRO under the terms of their own confidentiality agreements.